← Leaderboards
Andrew J Murphy
St. Jude Children'S Research Hospital
$1,184,821
Attributed
$1,184,821
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $265.1K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,184,821 · 1
By mechanism
K08$1,184,821 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$58,784,651
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$41,535,815
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
ComplexDemethylation17p13.1Behavior In VitroAnaplasiaCrispr/Cas TechnologyBiologyApoptosisCancer CellCancer PatientCareer DevelopmentCell BehaviorBiological ModelsCell LineCellsCell SurvivalCessation Of LifeBiometryChemotherapyChildhood Renal NeoplasmChromosomesCodeCombatDetection
Grant awards (5)
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor$194,741
K08 · FY2025 · CA · contact PI
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor$194,741
K08 · FY2024 · CA · contact PI
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor$265,113
K08 · FY2023 · CA · contact PI
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor$265,113
K08 · FY2022 · CA · contact PI
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor$265,113
K08 · FY2021 · CA · contact PI